Evoke Pharma is a biotechnology company focused on developing and commercializing innovative treatments for gastrointestinal disorders, particularly those affecting the gastrointestinal tract and leading to issues such as gastroparesis. Their primary objective is to create therapeutic solutions that enhance patient care and address unmet medical needs within this specialized area. By leveraging their expertise in drug development and a deep understanding of gastrointestinal diseases, Evoke Pharma aims to improve the quality of life for patients suffering from these challenging conditions. Read More
Evoke Pharma Inc (NASDAQ:EVOK) shares are trading higher Monday after the company presented GLP-1 data for users with diabetic gastoparesis using GIMOTI showing statistically significant improvements.
Shares of Wipro Limited (NYSE: WIT) rose sharply during Friday’s session after the company reported third-quarter financial results, issued guidance and declared an interim dividend. Wipro shares jumped 16.7% to $6.27 on Friday.
Shares of VCI Global Limited (NASDAQ: VCIG) fell sharply in pre-market trading after the company announced pricing of $2.75 million public offering. VCI Global shares tumbled 29.5% to $1.10 in pre-market trading Here are some other stocks moving in pre-market trading.
